Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medical Silk Fibroin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4748029
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 123 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Silk Fibroin market size was valued at US$ 98 million in 2025 and is forecast to a readjusted size of US$ 173 million by 2032 with a CAGR of 8.5% during review period.
Sik fibroin (SF is a natural high polymer fibroin exracted from sik,the content of whichis about 70%6 t0 80% ofthe silk,containing 18 kinds of amino ads, whichincludes8 kinds of essenial amin aids, gycine (Gy, alanine (Ala) and seine (Ser accounted for more than 80% of the tolal composion.sik ibroin itseli has good mechanical properies and physicochemical propertes, goo flexibility and tensile strength, breathability and moisture permeability, and slow releasee. Medical silk fibroin has good biocompatibility, good cell adhesion, can induce cell differentiation and tissue regeneration, and is biodegradable, which can reduce inflammation and the risk of secondary surgery.
One of the primary growth factors for the Silk Fibroin market is its burgeoning application in the biomedical field. Silk fibroinÂ’s biocompatibility, biodegradability, and mechanical robustness make it an ideal material for various biomedical applications, such as tissue engineering, drug delivery systems, and wound healing. Growing investments in healthcare infrastructure and the increasing prevalence of chronic diseases necessitating advanced medical treatments are further propelling the demand for silk fibroin-based biomedical products. Additionally, the research and development activities focused on creating innovative biomedical applications of silk fibroin are propelling market growth.
This report is a detailed and comprehensive analysis for global Medical Silk Fibroin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Silk Fibroin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical Silk Fibroin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical Silk Fibroin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical Silk Fibroin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Silk Fibroin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Silk Fibroin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seidecosa, Caresilk, Seiren Co., DSM, Dadilan, LANXESS, Huzhou Xintiansi Bio-tech, Huzhou Aotesi Biochemical, Hanzhou Linran, Suzhou Suhao Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Silk Fibroin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Market segment by Application
Medical
Plastic Surgery/Medical Beauty
Other
Major players covered
Seidecosa
Caresilk
Seiren Co.
DSM
Dadilan
LANXESS
Huzhou Xintiansi Bio-tech
Huzhou Aotesi Biochemical
Hanzhou Linran
Suzhou Suhao Bio
Chongqing Haifan Biochemical
Cathaya
Zhejiang Xingyue Biotechnology Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Silk Fibroin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Silk Fibroin, with price, sales quantity, revenue, and global market share of Medical Silk Fibroin from 2021 to 2026.
Chapter 3, the Medical Silk Fibroin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Silk Fibroin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Silk Fibroin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Silk Fibroin.
Chapter 14 and 15, to describe Medical Silk Fibroin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Silk Fibroin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Silk Fibroin Powder
    • 1.3.3 Silk Amino Acids
    • 1.3.4 Silk Peptide
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Silk Fibroin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Medical
    • 1.4.3 Plastic Surgery/Medical Beauty
    • 1.4.4 Other
  • 1.5 Global Medical Silk Fibroin Market Size & Forecast
    • 1.5.1 Global Medical Silk Fibroin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Medical Silk Fibroin Sales Quantity (2021-2032)
    • 1.5.3 Global Medical Silk Fibroin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Seidecosa
    • 2.1.1 Seidecosa Details
    • 2.1.2 Seidecosa Major Business
    • 2.1.3 Seidecosa Medical Silk Fibroin Product and Services
    • 2.1.4 Seidecosa Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Seidecosa Recent Developments/Updates
  • 2.2 Caresilk
    • 2.2.1 Caresilk Details
    • 2.2.2 Caresilk Major Business
    • 2.2.3 Caresilk Medical Silk Fibroin Product and Services
    • 2.2.4 Caresilk Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Caresilk Recent Developments/Updates
  • 2.3 Seiren Co.
    • 2.3.1 Seiren Co. Details
    • 2.3.2 Seiren Co. Major Business
    • 2.3.3 Seiren Co. Medical Silk Fibroin Product and Services
    • 2.3.4 Seiren Co. Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Seiren Co. Recent Developments/Updates
  • 2.4 DSM
    • 2.4.1 DSM Details
    • 2.4.2 DSM Major Business
    • 2.4.3 DSM Medical Silk Fibroin Product and Services
    • 2.4.4 DSM Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 DSM Recent Developments/Updates
  • 2.5 Dadilan
    • 2.5.1 Dadilan Details
    • 2.5.2 Dadilan Major Business
    • 2.5.3 Dadilan Medical Silk Fibroin Product and Services
    • 2.5.4 Dadilan Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Dadilan Recent Developments/Updates
  • 2.6 LANXESS
    • 2.6.1 LANXESS Details
    • 2.6.2 LANXESS Major Business
    • 2.6.3 LANXESS Medical Silk Fibroin Product and Services
    • 2.6.4 LANXESS Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 LANXESS Recent Developments/Updates
  • 2.7 Huzhou Xintiansi Bio-tech
    • 2.7.1 Huzhou Xintiansi Bio-tech Details
    • 2.7.2 Huzhou Xintiansi Bio-tech Major Business
    • 2.7.3 Huzhou Xintiansi Bio-tech Medical Silk Fibroin Product and Services
    • 2.7.4 Huzhou Xintiansi Bio-tech Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Huzhou Xintiansi Bio-tech Recent Developments/Updates
  • 2.8 Huzhou Aotesi Biochemical
    • 2.8.1 Huzhou Aotesi Biochemical Details
    • 2.8.2 Huzhou Aotesi Biochemical Major Business
    • 2.8.3 Huzhou Aotesi Biochemical Medical Silk Fibroin Product and Services
    • 2.8.4 Huzhou Aotesi Biochemical Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Huzhou Aotesi Biochemical Recent Developments/Updates
  • 2.9 Hanzhou Linran
    • 2.9.1 Hanzhou Linran Details
    • 2.9.2 Hanzhou Linran Major Business
    • 2.9.3 Hanzhou Linran Medical Silk Fibroin Product and Services
    • 2.9.4 Hanzhou Linran Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hanzhou Linran Recent Developments/Updates
  • 2.10 Suzhou Suhao Bio
    • 2.10.1 Suzhou Suhao Bio Details
    • 2.10.2 Suzhou Suhao Bio Major Business
    • 2.10.3 Suzhou Suhao Bio Medical Silk Fibroin Product and Services
    • 2.10.4 Suzhou Suhao Bio Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Suzhou Suhao Bio Recent Developments/Updates
  • 2.11 Chongqing Haifan Biochemical
    • 2.11.1 Chongqing Haifan Biochemical Details
    • 2.11.2 Chongqing Haifan Biochemical Major Business
    • 2.11.3 Chongqing Haifan Biochemical Medical Silk Fibroin Product and Services
    • 2.11.4 Chongqing Haifan Biochemical Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Chongqing Haifan Biochemical Recent Developments/Updates
  • 2.12 Cathaya
    • 2.12.1 Cathaya Details
    • 2.12.2 Cathaya Major Business
    • 2.12.3 Cathaya Medical Silk Fibroin Product and Services
    • 2.12.4 Cathaya Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Cathaya Recent Developments/Updates
  • 2.13 Zhejiang Xingyue Biotechnology Co., Ltd
    • 2.13.1 Zhejiang Xingyue Biotechnology Co., Ltd Details
    • 2.13.2 Zhejiang Xingyue Biotechnology Co., Ltd Major Business
    • 2.13.3 Zhejiang Xingyue Biotechnology Co., Ltd Medical Silk Fibroin Product and Services
    • 2.13.4 Zhejiang Xingyue Biotechnology Co., Ltd Medical Silk Fibroin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Zhejiang Xingyue Biotechnology Co., Ltd Recent Developments/Updates

3 Competitive Environment: Medical Silk Fibroin by Manufacturer

  • 3.1 Global Medical Silk Fibroin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medical Silk Fibroin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medical Silk Fibroin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medical Silk Fibroin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medical Silk Fibroin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medical Silk Fibroin Manufacturer Market Share in 2025
  • 3.5 Medical Silk Fibroin Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Silk Fibroin Market: Region Footprint
    • 3.5.2 Medical Silk Fibroin Market: Company Product Type Footprint
    • 3.5.3 Medical Silk Fibroin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Silk Fibroin Market Size by Region
    • 4.1.1 Global Medical Silk Fibroin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medical Silk Fibroin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medical Silk Fibroin Average Price by Region (2021-2032)
  • 4.2 North America Medical Silk Fibroin Consumption Value (2021-2032)
  • 4.3 Europe Medical Silk Fibroin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medical Silk Fibroin Consumption Value (2021-2032)
  • 4.5 South America Medical Silk Fibroin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medical Silk Fibroin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 5.2 Global Medical Silk Fibroin Consumption Value by Type (2021-2032)
  • 5.3 Global Medical Silk Fibroin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 6.2 Global Medical Silk Fibroin Consumption Value by Application (2021-2032)
  • 6.3 Global Medical Silk Fibroin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 7.2 North America Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 7.3 North America Medical Silk Fibroin Market Size by Country
    • 7.3.1 North America Medical Silk Fibroin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medical Silk Fibroin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medical Silk Fibroin Market Size by Country
    • 8.3.1 Europe Medical Silk Fibroin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medical Silk Fibroin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medical Silk Fibroin Market Size by Region
    • 9.3.1 Asia-Pacific Medical Silk Fibroin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medical Silk Fibroin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 10.2 South America Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 10.3 South America Medical Silk Fibroin Market Size by Country
    • 10.3.1 South America Medical Silk Fibroin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medical Silk Fibroin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Silk Fibroin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medical Silk Fibroin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medical Silk Fibroin Market Size by Country
    • 11.3.1 Middle East & Africa Medical Silk Fibroin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medical Silk Fibroin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medical Silk Fibroin Market Drivers
  • 12.2 Medical Silk Fibroin Market Restraints
  • 12.3 Medical Silk Fibroin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Silk Fibroin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Silk Fibroin
  • 13.3 Medical Silk Fibroin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Silk Fibroin Typical Distributors
  • 14.3 Medical Silk Fibroin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Silk Fibroin. Industry analysis & Market Report on Medical Silk Fibroin is a syndicated market report, published as Global Medical Silk Fibroin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Silk Fibroin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo